Clover Health Investments (CLOV) Cost of Revenue (2020 - 2026)

Clover Health Investments' Cost of Revenue history runs 7 years deep, the most recent figure standing at $589.6 million for Q1 2026.

• Quarterly Cost of Revenue rose 66.83% year-over-year to $589.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 64.86% YoY) and the FY2025 annual result came in at $1.6 billion, up 55.85% from the prior year.
• Cost of Revenue was $589.6 million for Q1 2026 at Clover Health Investments, up from $413.5 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $861.7 million in Q1 2022 and bottomed at -$1.6 billion in Q4 2022.
• A 5-year average of $303.6 million and a median of $274.8 million in 2023 frame the typical range for Cost of Revenue.
• Peak annual rise in Cost of Revenue reached 301.89% in 2022, while the deepest fall reached 454.63% in 2022.
• Clover Health Investments' Cost of Revenue stood at -$1.6 billion in 2022, then jumped by 115.94% to $249.8 million in 2023, then slipped by 2.69% to $243.0 million in 2024, then jumped by 70.13% to $413.5 million in 2025, then jumped by 42.6% to $589.6 million in 2026.
• Business Quant data shows CLOV's Cost of Revenue at $589.6 million in Q1 2026, $413.5 million in Q4 2025, and $423.5 million in Q3 2025.